Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $543.4900 (-1.78%) ($543.4900 - $552.6900) on Mon. Oct. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.61% (three month average) | RSI | 19 | Latest Price | $543.4900(-1.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN declines -3.3% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(53%) XLV(41%) DIA(39%) IWD(38%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -0.805% in a week (0% probabilities). VIXM(-21%) UUP(-7%) TBT(-7%) VXX(-5%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.805% (StdDev 1.61%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $579.05 | 5 Day Moving Average | $548.66(-0.94%) | 10 Day Moving Average | $548.86(-0.98%) | 20 Day Moving Average | $579.05(-6.14%) | To recent high | -20.6% | To recent low | 0.1% | Market Cap | $57.626b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |